Insulet Corporation Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 9 | $0.40 | $0.40 | $0.40 |
Q2 2024 | 6 | $0.56 | $0.56 | $0.56 |
Q3 2024 | 14 | $0.71 | $0.88 | $0.78 |
Q4 2024 | 6 | $1.01 | $1.01 | $1.01 |
Q1 2025 | 7 | $0.77 | $0.77 | $0.77 |
Q2 2025 | 7 | $0.82 | $0.82 | $0.82 |
Q3 2025 | 13 | $1.00 | $1.00 | $1.00 |
Q4 2025 | 7 | $1.23 | $1.23 | $1.23 |
Q1 2026 | 6 | $0.96 | $0.96 | $0.96 |
Q2 2026 | 10 | $1.03 | $1.03 | $1.03 |
Q3 2026 | 6 | $1.29 | $1.29 | $1.29 |
Q4 2026 | 8 | $1.52 | $1.52 | $1.52 |
Insulet Corporation Earnings Date And Information
Insulet Corporation last posted its earnings results on Thursday, August 8th, 2024. The company reported $0.55 earnings per share for the quarter, missing analysts' consensus estimates of $0.564 by $0.014. The company had revenue of 488.50 M for the quarter and had revenue of 1.70 B for the year. Insulet Corporation has generated $3 earnings per share over the last year ($2.94 diluted earnings per share) and currently has a price-to-earnings ratio of 43.42. Insulet Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Insulet Corporation Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/08/2024 | Q2 2024 | $2.69 | $488.00 M | $488.50 M | ||
05/09/2024 | Q1 2024 | $0.74 | $441.70 M | |||
02/22/2024 | Q4 2023 | $1.48 | $509.80 M | |||
11/02/2023 | Q3 2023 | $0.74 | $414.32 M | $432.70 M | ||
08/08/2023 | Q2 2023 | $0.39 | $385.26 M | $396.50 M | ||
05/04/2023 | Q1 2023 | $0.34 | $358.10 M | |||
02/23/2023 | Q4 2022 | $0.24 | $369.70 M | |||
11/03/2022 | Q3 2022 | -$0.07 | $312.11 M | $340.80 M | ||
08/04/2022 | Q2 2022 | -$0.50 | $291.45 M | $299.40 M | ||
05/05/2022 | Q1 2022 | $0.40 | $295.40 M | |||
02/23/2022 | Q4 2021 | $0.42 | $307.70 M | |||
11/04/2021 | Q3 2021 | $0.18 | $272.62 M | $275.60 M | ||
08/05/2021 | Q2 2021 | -$0.37 | $258.88 M | $263.20 M | ||
05/06/2021 | Q1 2021 | $0.01 | $252.30 M | |||
02/23/2021 | Q4 2020 | -$0.26 | $246.10 M | |||
11/04/2020 | Q3 2020 | $0.18 | $221.72 M | $234.00 M | ||
08/06/2020 | Q2 2020 | $0.22 | $212.41 M | $226.30 M | ||
05/07/2020 | Q1 2020 | -$0.03 | $198.00 M | |||
02/25/2020 | Q4 2019 | $0.08 | $209.40 M | |||
11/05/2019 | Q3 2019 | $0.01 | $179.49 M | $192.12 M |
Insulet Corporation Earnings: Frequently Asked Questions
-
When is Insulet Corporation's earnings date?
Insulet Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
How can I listen to Insulet Corporation's earnings conference call?
The conference call for Insulet Corporation's latest earnings report can be listened to online.
-
How can I read Insulet Corporation's conference call transcript?
The conference call transcript for Insulet Corporation's latest earnings report can be read online.
-
How much revenue does Insulet Corporation generate each year?
Insulet Corporation (:PODD) has a recorded annual revenue of $1.70 B.
-
How much profit does Insulet Corporation generate each year?
Insulet Corporation (:PODD) has a recorded net income of $1.70 B. Insulet Corporation has generated $2.96 earnings per share over the last four quarters.
-
What is Insulet Corporation's price-to-earnings ratio?
Insulet Corporation (:PODD) has a price-to-earnings ratio of 43.42 and price/earnings-to-growth ratio is 0.63.